Literature DB >> 28169977

Meta-Analysis of Odds Ratios: Current Good Practices.

Bei-Hung Chang1, David C Hoaglin.   

Abstract

BACKGROUND: Many systematic reviews of randomized clinical trials lead to meta-analyses of odds ratios (ORs). The customary methods of estimating an overall OR involve weighted averages of the individual trials' estimates of the logarithm of the OR. That approach, however, has several shortcomings, arising from assumptions and approximations, that render the results unreliable. Although the problems have been documented in the literature for many years, the conventional methods persist in software and applications. A well-developed alternative approach avoids the approximations by working directly with the numbers of subjects and events in the arms of the individual trials.
OBJECTIVE: We aim to raise awareness of methods that avoid the conventional approximations, can be applied with widely available software, and produce more-reliable results.
METHODS: We summarize the fixed-effect and random-effects approaches to meta-analysis; describe conventional, approximate methods and alternative methods; apply the methods in a meta-analysis of 19 randomized trials of endoscopic sclerotherapy in patients with cirrhosis and esophagogastric varices; and compare the results. We demonstrate the use of SAS, Stata, and R software for the analysis.
RESULTS: In the example, point estimates and confidence intervals for the overall log-odds-ratio differ between the conventional and alternative methods, in ways that can affect inferences. Programming is straightforward in the 3 software packages; an appendix, Suppemental Digital Content 1 (http://links.lww.com/MLR/B335) gives the details.
CONCLUSIONS: The modest additional programming required should not be an obstacle to adoption of the alternative methods. Because their results are unreliable, use of the conventional methods for meta-analysis of ORs should be discontinued.

Entities:  

Mesh:

Year:  2017        PMID: 28169977      PMCID: PMC5352535          DOI: 10.1097/MLR.0000000000000696

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  17 in total

1.  Weighting bias in meta-analysis of binary outcomes.

Authors:  J L Tang
Journal:  J Clin Epidemiol       Date:  2000-11       Impact factor: 6.437

2.  Misunderstandings about Q and 'Cochran's Q test' in meta-analysis.

Authors:  David C Hoaglin
Journal:  Stat Med       Date:  2015-08-24       Impact factor: 2.373

3.  The binomial distribution of meta-analysis was preferred to model within-study variability.

Authors:  Taye H Hamza; Hans C van Houwelingen; Theo Stijnen
Journal:  J Clin Epidemiol       Date:  2007-08-23       Impact factor: 6.437

4.  Investigating underlying risk as a source of heterogeneity in meta-analysis.

Authors:  S G Thompson; T C Smith; S J Sharp
Journal:  Stat Med       Date:  1997-12-15       Impact factor: 2.373

5.  Drug safety meta-analysis: promises and pitfalls.

Authors:  Michael A Stoto
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  A general framework for the use of logistic regression models in meta-analysis.

Authors:  Mark C Simmonds; Julian Pt Higgins
Journal:  Stat Methods Med Res       Date:  2014-05-12       Impact factor: 3.021

8.  Combination of direct and indirect evidence in mixed treatment comparisons.

Authors:  G Lu; A E Ades
Journal:  Stat Med       Date:  2004-10-30       Impact factor: 2.373

9.  Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.

Authors:  Sofia Dias; Alex J Sutton; A E Ades; Nicky J Welton
Journal:  Med Decis Making       Date:  2012-10-26       Impact factor: 2.583

10.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.

Authors:  Joanna IntHout; John P A Ioannidis; George F Borm
Journal:  BMC Med Res Methodol       Date:  2014-02-18       Impact factor: 4.615

View more
  24 in total

1.  Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.

Authors:  Joellen M Schildkraut; Lauren C Peres; Traci N Bethea; Fabian Camacho; Deanna Chyn; Emily K Cloyd; Elisa V Bandera; Alicia Beeghly-Fadiel; Loren Lipworth; Charlotte E Joslin; Faith G Davis; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Veronica Wendy Setiawan; Malcolm C Pike; Anna H Wu; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2019-06-24       Impact factor: 2.506

2.  Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  Maria Katsigianni; Vasilios Karageorgiou; Irene Lambrinoudaki; Charalampos Siristatidis
Journal:  Mol Psychiatry       Date:  2019-03-13       Impact factor: 15.992

3.  Meta-analysis of tadpole taste tests: consumption of anuran prey across development and predator strategies.

Authors:  Jennifer L Stynoski; Katherine Porras-Brenes
Journal:  Oecologia       Date:  2022-07-20       Impact factor: 3.298

4.  Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium.

Authors:  Heather M Ochs-Balcom; Courtney Johnson; Kristin A Guertin; Bo Qin; Alicia Beeghly-Fadiel; Fabian Camacho; Traci N Bethea; Lauren F Dempsey; Will Rosenow; Charlotte E Joslin; Evan Myers; Patricia G Moorman; Holly R Harris; Lauren C Peres; V Wendy Setiawan; Anna H Wu; Lynn Rosenberg; Joellen M Schildkraut; Elisa V Bandera
Journal:  Br J Cancer       Date:  2022-09-22       Impact factor: 9.075

5.  Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls.

Authors:  Damien Etchecopar-Etchart; Roxane Mignon; Laurent Boyer; Guillaume Fond
Journal:  Mol Psychiatry       Date:  2022-07-08       Impact factor: 13.437

Review 6.  Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co-occuring smoking: A systematic review and meta-analysis.

Authors:  Carissa van den Berk-Clark; Scott Secrest; Jesse Walls; Ellen Hallberg; Patrick J Lustman; F David Schneider; Jeffrey F Scherrer
Journal:  Health Psychol       Date:  2018-05       Impact factor: 4.267

Review 7.  Attention deficit and hyperactivity disorder and nocturnal enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis.

Authors:  Ana Cecília de Sena Oliveira; Bruno da Silva Athanasio; Flávia Cristina de Carvalho Mrad; Monica Maria de Almeida Vasconcelos; Maicon Rodrigues Albuquerque; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-05-19       Impact factor: 3.714

Review 8.  The Effects of Nonclinician Guidance on Effectiveness and Process Outcomes in Digital Mental Health Interventions: Systematic Review and Meta-analysis.

Authors:  Calista Leung; Julia Pei; Kristen Hudec; Farhud Shams; Richard Munthali; Daniel Vigo
Journal:  J Med Internet Res       Date:  2022-06-15       Impact factor: 7.076

9.  Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.

Authors:  Colette P Davis; Elisa V Bandera; Traci N Bethea; Fabian Camacho; Charlotte E Joslin; Anna H Wu; Alicia Beeghly-Fadiel; Patricia G Moorman; Evan R Myers; Heather M Ochs-Balcom; Lauren C Peres; Will T Rosenow; Veronica W Setiawan; Lynn Rosenberg; Joellen M Schildkraut; Holly R Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-21       Impact factor: 4.254

Review 10.  Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.

Authors:  Innocent G Asiimwe; Sudeep Pushpakom; Richard M Turner; Ruwanthi Kolamunnage-Dona; Andrea L Jorgensen; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2021-07-07       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.